Softwr

Research · head to head

Greenphire vs Scispot

Greenphire logo

Greenphire

Research

Clinical trial participant payments, reimbursement and travel, now part of Suvoda

From
On request
Rated
-
Full reviewWebsite
Scispot logo

Scispot

Research

No-code lab operating system combining LIMS, ELN and inventory for biotech teams

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Greenphire the standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.; Scispot pricing is presented as four dollar sign bands with no figures, so a vendor whose marketing attacks competitor pricing opacity requires a discovery call before telling you its own numbers.
  • They diverge on capability: Greenphire covers ClinCard, Scispot covers No-code configuration.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Greenphire and Scispot actually diverge.

Attributes where Greenphire and Scispot differ
AttributeGreenphireScispot
PlatformsWeb, iOS, AndroidWeb, API

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Greenphire

  • ClinCard
  • Direct to bank payment
  • Expense reimbursement
  • Travel and logistics
  • Site payments
  • Budgeting and benchmarking
  • Tax handling

Only in Scispot

  • No-code configuration
  • LIMS and ELN together
  • Inventory management
  • Instrument integration
  • Audit trails and e-signatures
  • API and data layer
  • Validation support
  • Integrations

What people use each for

The jobs each tool is most often brought in to do.

Greenphire

  • A global Phase III trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payablenot Scispot
  • A decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodationnot Scispot
  • A trial in a population where slow reimbursement drives dropout and same day payment materially helps retentionnot Scispot
  • A sponsor that wants site payment milestones and participant payments handled by one vendor rather than twonot Scispot

Scispot

  • A Series A biotech replacing a folder of spreadsheets before a partner or investor audit exposes the gapnot Greenphire
  • A diagnostics company that needs sample chain of custody and electronic signatures without a year-long LIMS implementationnot Greenphire
  • A contract research organisation configuring different workflows per client without buying a separate instance each timenot Greenphire
  • A computational team that wants laboratory data queryable through an API rather than exported by handnot Greenphire

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Greenphire

  • The standalone greenphire.com site now redirects to Suvoda and the brands have been integrated, so buyers are contracting with a randomisation and supply vendor and should expect cross selling rather than an independent payments specialist.
  • Nothing is published on price, and the typical shape of a platform fee plus per participant and per transaction charges means the cost of a trial is not knowable until enrolment is known.
  • Payment method availability varies sharply by country, so a global protocol may end up with card payments in some regions and slow manual processes in others, which undermines the retention argument that justified the purchase.
  • Sites bear the administrative work of enrolling participants and triggering payments but are not the buyer, so adoption depends on the sponsor mandating it and site resistance is a real implementation risk.
  • Participant payments create tax reporting obligations that differ per jurisdiction, and the tooling helps but does not remove sponsor liability, so legal and finance review is required in every country the trial runs in.

Scispot

  • Pricing is presented as four dollar sign bands with no figures, so a vendor whose marketing attacks competitor pricing opacity requires a discovery call before telling you its own numbers.
  • Compliance capability is bundled into tier scope rather than itemised, which makes it hard to tell at purchase whether the tier you are quoted actually covers the Part 11 controls your auditor will ask for.
  • Validation remains your responsibility: the vendor supplies support and correctly states that no platform makes a lab compliant, but the documentation effort and its cost sit with your quality function.
  • It is a young and small vendor holding your primary scientific record, so business continuity, data escrow and full export guarantees need to be settled contractually rather than assumed.
  • Instrument integration breadth is narrower than the established LIMS vendors, so labs with older or unusual analysers may need custom connector work that undercuts the no-code promise.

Pricing, plan by plan

Greenphire

On request
  • Greenphire Patient Payments$undefined/year
    • Priced per study through a sales process
    • Typically a platform fee plus per participant and per transaction charges
    • Funding of the payment float is separate from the software fee

Scispot

On request
  • Scispot$undefined/year
    • Custom annual pricing released after a discovery call
    • Four relative investment tiers shown only as dollar sign bands
    • Mid tier adds roles, e-signatures, approvals, audit trails and validation support

Which should you pick?

Choose Greenphire if

  • You need clincard.
  • You work on Web, iOS, Android.
  • You also want direct to bank payment.
Greenphire review

Choose Scispot if

  • You need no-code configuration.
  • You work on Web, API.
  • You also want lims and eln together.
Scispot review

Questions people ask

Is Greenphire or Scispot better?
Neither clearly leads. Greenphire starts at On request and Scispot at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Greenphire or Scispot?
Greenphire starts at On request and Scispot at On request.
Does Greenphire or Scispot run on more platforms?
Greenphire runs on Web, iOS, Android. Scispot runs on Web, API.
What is Greenphire best used for?
Greenphire is most often used for a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable, a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation, a trial in a population where slow reimbursement drives dropout and same day payment materially helps retention, a sponsor that wants site payment milestones and participant payments handled by one vendor rather than two. Of those, a global phase iii trial paying stipends across many countries where participants cannot practically be reimbursed by sponsor accounts payable and a decentralised or hybrid trial where participants travel long distances and the sponsor funds flights and accommodation are not what Scispot is typically brought in for.
What can Greenphire do that Scispot cannot?
Greenphire covers ClinCard, Direct to bank payment, Expense reimbursement, Travel and logistics. Scispot covers No-code configuration, LIMS and ELN together, Inventory management, Instrument integration.

Answered from the vendors’ own pages

Greenphire: Is Greenphire still sold?

Yes, as Greenphire Patient Payments on the Suvoda platform. The independent website and social presence have been consolidated into Suvoda.

Scispot: How much does Scispot cost?

It does not publish figures. The pricing page shows four relative investment tiers as dollar sign bands, with real numbers given after a discovery call.

Greenphire: What is ClinCard?

The reloadable debit card Greenphire issues to participants. Greenphire Patient Payments was formerly known as ClinCard.

Scispot: Does it support 21 CFR Part 11?

It can be configured for Part 11 controlled workflows with roles, e-signatures, approvals and audit trails from the mid tier, and it supports ALCOA+ principles. Validation of your configuration is still your responsibility.

Greenphire: Does it publish pricing?

No. Pricing is per study and quoted through sales, and funding the payments themselves is separate from the software fee.

Scispot: Is it a LIMS or an ELN?

Both, plus inventory, in one subscription rather than separately licensed products.

Greenphire: Can it pay participants outside the United States?

Yes, in more than thirty currencies, but the available payment method depends on the country.

Scispot: Who is it not for?

Large regulated manufacturers with existing validated LIMS estates, and any lab that needs deep integration with an unusual analyser fleet.

Share

Related pages

More on Greenphire

More on Scispot

Keep looking

Other head to heads